Metagenomics Market - Forecast(2022 - 2027)

Report Code: HCR 17293 Report Format: PDF + Excel

Metagenomics Market Overview

Metagenomics Market size is estimated to reach $1.5 billion by 2027, growing at a CAGR of 16.2% during the forecast period 2022-2027. Metagenomics is the examination of genetic material reclaimed directly from environmental samples. The expansive field may also be specified as environmental genomics, eco-genomics or community genomics. Shotgun metagenomic sequencing is a comparatively novel environmental sequencing technique utilized to analyze thousands of organisms in parallel and completely sample all genes, offering acumen into community biodiversity and function. 16S rRNA gene sequencing is typically restricted to recognizing bacteria at the genus level (e.g. Bifidobacteria). De novo assembly has been a necessary instrument in current investigations in metagenomics viral analysis. Glycoside hydrolases (GHs) are amidst the industrially significant enzymes that are widely explored by way of metagenomics owing to their very great expedience and significance in food and additional industrial sectors. Whole-genome sequencing offers added information on the nature and localization of antimicrobial resistance factors and on their dissemination possibility by horizontal gene delivery, and on genes connecting to virulence and biological fitness. Interoperable data will play a principal role in the forthcoming utilization of whole genome sequencing and metagenomic data.

The COVID-19 pandemic is set to drive the Metagenomics Market owing to the extensive utilization of technologies like Metagenomics in pandemic hazard computations to detect the molecular alterations in pathogens at the time of their worldwide rise, which could help in the forecast of rising hotspots, populations at risk, and the pathogens under genetic evolution as per the research article issued in Future Science, 2021. The burgeoning interest of researchers in related new research fields like metatranscriptomics, metaproteomics, and metabolomics has inspired microbiologists to investigate related workflows` in conjunction with novel techniques like shotgun metagenomic sequencing and is set to propel the growth of the Metagenomics Market during the forecast period 2022-2027. This represents the Metagenomics Industry Outlook.

Report Coverage

The report: Metagenomics Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Metagenomics Market.

By Product: Sequencing And Data Analytics Services, Kits And Reagents, Others.
By Technology: Sequencing Driven, Function Driven.
By Application: Human Health, Environmental, Others.
By Geography: North America (the U.S, Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), Europe (Germany, France, UK, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), and Rest Of The World (Middle East, Africa). 

Key Takeaways

  • Geographically, North America Metagenomics Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the existence of a soaring count of pharmaceutical and biotechnological firms developing new and effective metagenomic platforms in conjunction with novel techniques like shotgun metagenomic sequencing in the North American region.
  • Metagenomics Market growth is being driven by the technological advancements in DNA sequencing in conjunction with the development of novel techniques like shotgun metagenomic sequencing. However, the soaring cost of complete metagenomics is one of the major factors hampering the growth of the Metagenomics Market.
  • Metagenomics Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Metagenomics Market report. 

    Metagenomics Market Share, By Product, 2021(%)

    Metagenomics Market Share

For More Details on This Report - Request for Sample

Metagenomics Market Segment Analysis – By Product:

The Metagenomics Market based on products can be further segmented into Sequencing And Data Analytics Services, Kits And Reagents, and Others. The Kits And Reagents Segment held the largest market share in 2021. This growth is owing to the considerable count of kits and reagents being introduced and utilized to back the increasing demand for library preparation workflows from research laboratories. The boost in the rate of application and the great infiltration in conjunction with the extensive application of shotgun metagenomic sequencing is further propelling the growth of the genome engineering segment.

Furthermore, the Sequencing And Data Analytics Services segment is estimated to grow with the fastest CAGR of 16.9% during the forecast period 2022-2027 owing to the accelerated and considerable cost minimization in next-generation sequencing which has productively expedited the growth of sequence-based metagenomics in conjunction with the soaring application of shotgun metagenomic sequencing.

Metagenomics Market Segment Analysis – By Technology:

The Metagenomics Market based on technology can be further segmented into Sequencing Driven and Function Driven. The Sequencing Driven Segment held the largest market share in 2021. This growth is owing to the soaring application of this technology. The burgeoning acceptance of this technology may be ascribed to the onset of new bioinformatics-associated solutions, which make workflows easy and offers accelerated outcomes. shotgun metagenomic sequencing permits researchers to exhaustively sample all genes in all organisms existing in a given complex sample. Surging endeavors to keep up a standard database and increase in the count of metagenome samples accumulated at data repositories are further propelling the growth of this segment.

Furthermore, the Function Driven segment is estimated to grow with the fastest CAGR of 17.1% during the forecast period 2022-2027 owing to the increasing application of function-driven metagenomics for protein screening applied to antibiotic resistance and vitamin manufacture in conjunction with the proliferating application of shotgun metagenomic sequencing.

Metagenomics Market Segment Analysis – By Geography:

The Metagenomics Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Metagenomics Market) held the largest share with 36% of the overall market in 2021. The growth of this region is owing to the surging spend on R&D. The extensive acceptance of metagenomic diagnostic, an expanding count of next-generation sequencing(NGS) based research endeavors in conjunction with increased application of shotgun metagenomic sequencing and the existence of key players like Illumina Inc., in the region are propelling the growth of the Metagenomics market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like consistent developments performed to build up the bioinformatics infrastructure and genomic landscape in nations like India and China. The considerable fluctuation in climate and environment in the region together with the heightening application of shotgun metagenomic sequencing is fuelling the progress of the Metagenomics market in the Asia-Pacific region.

Metagenomics Market Drivers

Increased Application Of Shotgun Metagenomic Sequencing Is Projected To Drive The Growth Of Metagenomics Market:

Shotgun metagenomic sequencing developed by Illumina Inc., permits researchers to completely sample all genes in all organisms existing in a given complex sample. The technique allows microbiologists to assess bacterial diversity and discover the profusion of microbes in different environments. Shotgun metagenomics also offers a means to investigate unculturable microorganisms that are otherwise hard or impossible to evaluate. Unlike capillary sequencing or PCR-based techniques, next-generation sequencing (NGS) permits researchers to sequence thousands of organisms in parallel. With the capability to integrate abundant samples in a single sequencing run and acquire high sequence coverage per sample, NGS-based metagenomic sequencing can discover very low abundance members of the microbial community that may be unnoticed or are too high-priced to recognize utilizing additional techniques. The surging application of shotgun metagenomic sequencing is fuelling the growth of the Metagenomics Market during the forecast period 2022-2027.

Benefits Of 16S rRNA Sequencing Are Expected To Boost The Demand Of Metagenomics:

16S rRNA Sequencing is a typical amplicon sequencing technique utilized to recognize and compare bacteria existing within a given sample. The prokaryotic 16S rRNA gene is almost 1500 bp long, with nine variable regions integrated between conserved regions. Variable regions of the 16S rRNA gene are generally utilized for the phylogenetic classification of genus or species in different microbial populations. An essential advantage of 16S rRNA Sequencing is that it offers an affordable method to recognize strains that may not be discovered utilizing conventional techniques. Unlike capillary sequencing or PCR-based techniques, next-generation sequencing (NGS) is a culture-free technique that allows investigation of the complete microbial community within a sample. 16S rRNA NGS permits microbiologists to accomplish genus-level sensitivity for metagenomic examinations of bacterial populations. The advantages of 16S rRNA Sequencing are driving the growth of the Metagenomics Market during the forecast period 2022-2027.

Metagenomics Market Challenges

Databases For Metagenomic Data Present Challenges To The Growth Of The Metagenomics Market:

Absorbing the sequence that will be produced by metagenomics projects will be demanding for the nucleic acid sequence data archive. Adding to the archiving challenge, it is evident that the community will need novel, secondary databases if the data are to be utilized efficiently. Only a specially-designed database will be able to provide constant storage and querying of the abundant metadata that metagenomic sequences require. The investigation of metagenomic sequences will need computational programs that are best provided in the context of a specially-designed database, for example, programs for the clustering of metagenomic sequence reads or for time-series analysis. And metagenomic data must be combined with data from distinct projects, like satellite data on ocean temperatures and time-series data on alterations in ocean salinity. This issue is hampering the growth of the Metagenomics Market.

Metagenomics Market Landscape:

Product launches, technological advancements, collaborations, mergers and acquisitions, financing in R&D activities, partnerships, and joint ventures are key strategies adopted by players in this Market. Metagenomics top 10 companies include:

  1. Thermo Fisher Scientific, Inc.
  2. QIAGEN
  3. Illumina, Inc.
  4. Promega Corporation
  5. Novogene Co., Ltd.
  6. Takara Bio, Inc
  7. Oxford Nanopore Technologies
  8. Arc Bio, LLC.
  9. Eurofins Scientific
  10. Zymo Research

Acquisitions/Product Launches:

  • In November 2021, QIAGEN declared the inclusion of StableScript™ to the OEM portfolio. The versatile reverse transcriptase is planned for application in one-step RT-qPCR and long-range RT-PCR and is accessible to order in bulk amounts. The launch of reverse transcriptases has permitted polymerase chain reaction (PCR) to be adapted to RNA and the establishment of cDNA libraries from mRNA.
  • In October 2021, QIAGEN N.V. declared the introduction and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis (TB) infection, to assist in accomplishing TB removal targets worldwide by boosting access to effortless and trustworthy TB testing, specifically in great burden countries, low-resource regions. A breakthrough in the battle against a pathogen estimated to be carried by over two billion people globally established on the proven QuantiFERON-TB Gold Plus technology, QIAreach® QuantiFERON®-TB is a portable instrument that allows the ultrasensitive digital discovery of TB infection with an end-to-end workflow that is clear and cost-efficient and raises access to trustworthy Interferon Gamma Release Assay (IGRA) testing. QIAGEN will target regions that encounter a huge burden of the ailment, and where procuring access to laboratory infrastructure and resources for testing is restricted.
  • In July 2021, QIAGEN N.V. declared the introduction of the Workflow Configurator, allowing researchers in the life sciences to effortlessly and speedily discover the best solutions to make their experiments perfect. Purchasers simply select their application, biological starting material, analyte, and analysis type. In seconds, the configurator arranges by way of hundreds of possible products to detect the most appropriate workflow and related products.

Related Reports:

Report Code: HCR 14761

Report Code: HCR 53283

For more Lifesciences and Healthcare Market reports, please click here

1. Metagenomics Market Overview
    1.1 Definitions and Scope
2. Metagenomics Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends By Product
    2.3 Key trends By Technology
    2.4 Key trends by Geography
3. Metagenomics Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Metagenomics Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Metagenomics Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Metagenomics Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Metagenomics Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Metagenomics Market - By Product (Market Size –$Million/$Billion) 
    8.1 Sequencing And Data Analytics Services
    8.2 Kits And Reagents
    8.3 Others
9. Metagenomics Market - By Technology (Market Size –$Million/$Billion) 
    9.1 Sequencing Driven
    9.2 Function Driven
10. Metagenomics Market – By Application (Market Size –$Million/$Billion) 
    10.1 Human Health
    10.2 Environmental
    10.3 Others
11. Metagenomics Market- By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest Of The World
        11.5.1 Middle East
        11.5.2 Africa
12. Metagenomics Market- Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs and partnerships
13. Metagenomics Market– Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Metagenomics Market– Key Company List by Country Premium (Premium)
15. Metagenomics Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"

LIST OF TABLES

1.Global Metagenomics Market, By Technology Market 2019-2024 ($M)
1.1 Sequencing Market 2019-2024 ($M) - Global Industry Research
1.1.1 And Opportunity Market 2019-2024 ($M)
1.2 Bioinformatics Market 2019-2024 ($M) - Global Industry Research
2.Global Metagenomics Market, By Product Market 2019-2024 ($M)
2.1 Consumables Market 2019-2024 ($M) - Global Industry Research
2.2 Instrument Software Market 2019-2024 ($M) - Global Industry Research
3.Global Metagenomics Market, By Technology Market 2019-2024 (Volume/Units)
3.1 Sequencing Market 2019-2024 (Volume/Units) - Global Industry Research
3.1.1 And Opportunity Market 2019-2024 (Volume/Units)
3.2 Bioinformatics Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Metagenomics Market, By Product Market 2019-2024 (Volume/Units)
4.1 Consumables Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Instrument Software Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Metagenomics Market, By Technology Market 2019-2024 ($M)
5.1 Sequencing Market 2019-2024 ($M) - Regional Industry Research
5.1.1 And Opportunity Market 2019-2024 ($M)
5.2 Bioinformatics Market 2019-2024 ($M) - Regional Industry Research
6.North America Metagenomics Market, By Product Market 2019-2024 ($M)
6.1 Consumables Market 2019-2024 ($M) - Regional Industry Research
6.2 Instrument Software Market 2019-2024 ($M) - Regional Industry Research
7.South America Metagenomics Market, By Technology Market 2019-2024 ($M)
7.1 Sequencing Market 2019-2024 ($M) - Regional Industry Research
7.1.1 And Opportunity Market 2019-2024 ($M)
7.2 Bioinformatics Market 2019-2024 ($M) - Regional Industry Research
8.South America Metagenomics Market, By Product Market 2019-2024 ($M)
8.1 Consumables Market 2019-2024 ($M) - Regional Industry Research
8.2 Instrument Software Market 2019-2024 ($M) - Regional Industry Research
9.Europe Metagenomics Market, By Technology Market 2019-2024 ($M)
9.1 Sequencing Market 2019-2024 ($M) - Regional Industry Research
9.1.1 And Opportunity Market 2019-2024 ($M)
9.2 Bioinformatics Market 2019-2024 ($M) - Regional Industry Research
10.Europe Metagenomics Market, By Product Market 2019-2024 ($M)
10.1 Consumables Market 2019-2024 ($M) - Regional Industry Research
10.2 Instrument Software Market 2019-2024 ($M) - Regional Industry Research
11.APAC Metagenomics Market, By Technology Market 2019-2024 ($M)
11.1 Sequencing Market 2019-2024 ($M) - Regional Industry Research
11.1.1 And Opportunity Market 2019-2024 ($M)
11.2 Bioinformatics Market 2019-2024 ($M) - Regional Industry Research
12.APAC Metagenomics Market, By Product Market 2019-2024 ($M)
12.1 Consumables Market 2019-2024 ($M) - Regional Industry Research
12.2 Instrument Software Market 2019-2024 ($M) - Regional Industry Research
13.MENA Metagenomics Market, By Technology Market 2019-2024 ($M)
13.1 Sequencing Market 2019-2024 ($M) - Regional Industry Research
13.1.1 And Opportunity Market 2019-2024 ($M)
13.2 Bioinformatics Market 2019-2024 ($M) - Regional Industry Research
14.MENA Metagenomics Market, By Product Market 2019-2024 ($M)
14.1 Consumables Market 2019-2024 ($M) - Regional Industry Research
14.2 Instrument Software Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Metagenomics Market Revenue, 2019-2024 ($M)
2.Canada Metagenomics Market Revenue, 2019-2024 ($M)
3.Mexico Metagenomics Market Revenue, 2019-2024 ($M)
4.Brazil Metagenomics Market Revenue, 2019-2024 ($M)
5.Argentina Metagenomics Market Revenue, 2019-2024 ($M)
6.Peru Metagenomics Market Revenue, 2019-2024 ($M)
7.Colombia Metagenomics Market Revenue, 2019-2024 ($M)
8.Chile Metagenomics Market Revenue, 2019-2024 ($M)
9.Rest of South America Metagenomics Market Revenue, 2019-2024 ($M)
10.UK Metagenomics Market Revenue, 2019-2024 ($M)
11.Germany Metagenomics Market Revenue, 2019-2024 ($M)
12.France Metagenomics Market Revenue, 2019-2024 ($M)
13.Italy Metagenomics Market Revenue, 2019-2024 ($M)
14.Spain Metagenomics Market Revenue, 2019-2024 ($M)
15.Rest of Europe Metagenomics Market Revenue, 2019-2024 ($M)
16.China Metagenomics Market Revenue, 2019-2024 ($M)
17.India Metagenomics Market Revenue, 2019-2024 ($M)
18.Japan Metagenomics Market Revenue, 2019-2024 ($M)
19.South Korea Metagenomics Market Revenue, 2019-2024 ($M)
20.South Africa Metagenomics Market Revenue, 2019-2024 ($M)
21.North America Metagenomics By Application
22.South America Metagenomics By Application
23.Europe Metagenomics By Application
24.APAC Metagenomics By Application
25.MENA Metagenomics By Application
26.Agilent Technologies, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Enterome Sa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.F Hoffmann-La Roche Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Illumina, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Oxford Nanopore Technology Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pacific Bioscience Of California, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Perkinelmer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Qiagen N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Swift Bioscience Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Thermo Fisher Scientific, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)